David Rubenstein interview Bill Anderson, Chief Executive Officer of Bayer AG.
Founded in 1863, Bayer AG is a German multinational pharmaceutical and biotechnology company and is one of the largest life sciences companies in the world. Headquartered in Leverkusen, Germany, Bayer is a global enedterprise with core competencies in agriculture, pharmaceuticals, and consumer health. It is represented in 83 countries with over 101,000 employees.
William N. (Bill) Anderson became the first American Chairman of the Board of Management and CEO of Bayer in 2023. Beginning in 2006, Mr. Anderson held various positions with Genentech and their parent company Roche Pharmaceuticals, eventually becoming CEO of Genentech in 2017 and CEO of Roche Pharmaceuticals in 2019. Previously, he held positions at a variety of chemical and biotechnology companies including Biogen, Raychem Corporation, and Ethyl Corporation.
He holds a Bachelor of Science from the University of Texas and a Master of Science from Massachusetts Institute of Technology, both in Chemical Engineering. He also holds a Master of Science in Management from MIT’s Sloan School.
